Anzeige
Mehr »
Login
Dienstag, 21.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
657 Leser
Artikel bewerten:
(2)

The Chemours Company: Chemours CEO Mark Newman Recognized As Delaware Business Times CEO of the Year

Finanznachrichten News

WILMINGTON, DE / ACCESSWIRE / July 20, 2023 / The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, is pleased to announce that its President and CEO, Mark Newman, has been recognized by the Delaware Business Times as its CEO of the Year award winner in the Large For-Profit category. Now in its third year, the awards program honors the efforts of Delaware's top-ranking business leaders in both for-profit and nonprofit sectors.

"I am truly honored to receive the CEO of the Year award from Delaware Business Times. We are grateful to be headquartered in Delaware and for our partnerships across the state. I am proud of our team's efforts to make a meaningful difference in the Greater Wilmington community," said Mark Newman. "This recognition is a testament to the hard work and dedication of the entire Chemours team. With their innovative thinking and unrelenting pursuit of excellence, Chemours is helping create a better world through the power of our chemistry. I am privileged to lead such an exceptional team, and I share this recognition with each and every one of them."

Mr. Newman has been part of Chemours leadership since the company's creation in 2015 and became President and CEO of the company in 2021 after previously serving as Chief Financial Officer and Chief Operating Officer. Since becoming chief executive, Mr. Newman has ushered in a new chapter for Chemours, focusing on the responsible manufacturing of more innovative and sustainable solutions, environmental leadership, societal and community impact and efforts to make Chemours the greatest place to work. Mark has also been a visible and vocal champion of inclusion, diversity, and equity (ID&E), embedding it as a part of the company's culture and ethos.

Mr. Newman accepted the honor at an awards ceremony at Deerfield Golf Club in Newark, DE on July 19.

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our flagship products are sold under prominent brands such as Ti-Pure, Opteon, Freon, Teflon, Viton, Nafion, and Krytox. The company has approximately 6,600 employees and 29 manufacturing sites serving approximately 2,900 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn.

CONTACTS:

INVESTORS
Brandon Ontjes
VP, Financial Planning & Analysis, and Investor Relations
+1.302.773.3300
investor@chemours.com

Kurt Bonner
Manager, Investor Relations
+1.302.773.0026
investor@chemours.com

NEWS MEDIA
Thom Sueta
Director, Corporate Communications
+1.302.773.3903
media@chemours.com

The Chemours Company, Thursday, July 20, 2023, Press release picture


View additional multimedia and more ESG storytelling from The Chemours Company on 3blmedia.com.

Contact Info:
Spokesperson: The Chemours Company
Website: https://www.3blmedia.com/profiles/chemours-company
Email: info@3blmedia.com

SOURCE: The Chemours Company

View source version on accesswire.com:
https://www.accesswire.com/769442/Chemours-CEO-Mark-Newman-Recognized-As-Delaware-Business-Times-CEO-of-the-Year

© 2023 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.